Loading…
Increased MDM2 expression is associated with inferior survival in mantle cell lymphoma, but not related to the MDM2 SNP309
* Institute of Pathology, University of Würzburg, Germany ° Hematopathology Section, Department of Pathology, Hospital Clinic, University of Barcelona, Spain Correspondence: Andreas Rosenwald, M.D., Institute of Pathology, University of Würzburg, Josef-Schneider-Str. 2, 97080 Würzburg, Germany. We h...
Saved in:
Published in: | Haematologica (Roma) 2007-04, Vol.92 (4), p.574-575 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | * Institute of Pathology, University of Würzburg, Germany
° Hematopathology Section, Department of Pathology, Hospital Clinic, University of Barcelona, Spain
Correspondence: Andreas Rosenwald, M.D., Institute of Pathology, University of Würzburg, Josef-Schneider-Str. 2, 97080 Würzburg, Germany.
We here show that increased expression of MDM2, a negative regulator of p53, correlates with inferior survival in a series of 43 mantle cell lymphomas. MDM2 overexpression is associated with copy number gains of the MDM2 locus in single tumors, but not with the recently reported MDM2 promoter SNP309.
Key words: mantle cell lymphoma, MDM2 expression, survival, SNP309. |
---|---|
ISSN: | 0390-6078 1592-8721 |
DOI: | 10.3324/haematol.10891 |